Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-109053
Filing Date
2025-08-14
Accepted
2025-08-14 17:09:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 17947
  Complete submission text file 0000950170-25-109053.txt   19747
Mailing Address 3RD FLOOR, 1 ASHLEY ROAD ALTRINCHAM CHESIRE X0 WA14 2DT
Business Address 3RD FLOOR, 1 ASHLEY ROAD ALTRINCHAM CHESIRE X0 WA14 2DT 1-716-676-6461
COMPASS Pathways plc (Subject) CIK: 0001816590 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92194 | Film No.: 251220884
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 228 HAMILTON AVENUE, 3RD FLOOR PALO ALTO CA 94301
Business Address 228 HAMILTON AVENUE, 3RD FLOOR PALO ALTO CA 94301 650-798-5495
TCG Crossover GP I, LLC (Filed by) CIK: 0001839947 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A